These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
357 related articles for article (PubMed ID: 12627083)
1. Pneumonectomy vs lobectomy in the treatment of pathologic N1 NSCLC: could the type of surgical resection dictate survival? Luzzi L; Voltolini L; Campione A; Paladini P; Ghiribelli C; Di Bisceglie M; Gotti G J Cardiovasc Surg (Torino); 2003 Feb; 44(1):119-23. PubMed ID: 12627083 [TBL] [Abstract][Full Text] [Related]
2. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer. Kang CH; Ra YJ; Kim YT; Jheon SH; Sung SW; Kim JH Ann Thorac Surg; 2008 Oct; 86(4):1092-7. PubMed ID: 18805138 [TBL] [Abstract][Full Text] [Related]
3. Prognostic factors in patients with pathologic T1-2N1M0 disease in non-small cell carcinoma of the lung. Matsuoka K; Sumitomo S; Misaki N J Thorac Oncol; 2007 Dec; 2(12):1098-102. PubMed ID: 18090581 [TBL] [Abstract][Full Text] [Related]
4. Local control of disease related to lymph node involvement in non-small cell lung cancer after sleeve lobectomy compared with pneumonectomy. Kim YT; Kang CH; Sung SW; Kim JH Ann Thorac Surg; 2005 Apr; 79(4):1153-61; discussion 1153-61. PubMed ID: 15797043 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer. Demir A; Turna A; Kocaturk C; Gunluoglu MZ; Aydogmus U; Urer N; Bedirhan MA; Gurses A; Dincer SI Ann Thorac Surg; 2009 Apr; 87(4):1014-22. PubMed ID: 19324121 [TBL] [Abstract][Full Text] [Related]
9. The present status of surgery for lung cancer. Lacquet LK Acta Chir Belg; 1996; 96(6):245-51. PubMed ID: 9008764 [TBL] [Abstract][Full Text] [Related]
10. Survival after bronchoplastic lobectomy for non small cell lung cancer compared with pneumonectomy according to nodal status. Ghiribelli C; Voltolini L; Luzzi L; Paladini P; Campione A; Gotti G J Cardiovasc Surg (Torino); 2002 Feb; 43(1):103-8. PubMed ID: 11803340 [TBL] [Abstract][Full Text] [Related]
11. Sleeve lobectomy for non-small cell lung cancer with N1 nodal disease does not compromise survival. Berry MF; Worni M; Wang X; Harpole DH; D'Amico TA; Onaitis MW Ann Thorac Surg; 2014 Jan; 97(1):230-5. PubMed ID: 24206972 [TBL] [Abstract][Full Text] [Related]
12. The role of sleeve resections in advanced nodal disease. Schirren J; Eberlein M; Fischer A; Bölükbas S Eur J Cardiothorac Surg; 2011 Nov; 40(5):1157-63. PubMed ID: 21454086 [TBL] [Abstract][Full Text] [Related]
13. Margin Distance Does Not Influence Recurrence and Survival After Wedge Resection for Lung Cancer. Maurizi G; D'Andrilli A; Ciccone AM; Ibrahim M; Andreetti C; Tierno S; Poggi C; Menna C; Venuta F; Rendina EA Ann Thorac Surg; 2015 Sep; 100(3):918-24; discussion 924-5. PubMed ID: 26209486 [TBL] [Abstract][Full Text] [Related]
14. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival. Decaluwé H; De Leyn P; Vansteenkiste J; Dooms C; Van Raemdonck D; Nafteux P; Coosemans W; Lerut T Eur J Cardiothorac Surg; 2009 Sep; 36(3):433-9. PubMed ID: 19502079 [TBL] [Abstract][Full Text] [Related]
15. Lymph Node Assessment and Impact on Survival in Video-Assisted Thoracoscopic Lobectomy or Segmentectomy. Zhou H; Tapias LF; Gaissert HA; Muniappan A; Wright CD; Wain JC; Donahue DM; Morse CR; Mathisen DJ; Lanuti M Ann Thorac Surg; 2015 Sep; 100(3):910-6. PubMed ID: 26165483 [TBL] [Abstract][Full Text] [Related]
16. Risk factors for local recurrence after lobectomy and lymph node dissection in patients with non-small cell lung cancer: Implications for adjuvant therapy. Isaka M; Kojima H; Takahashi S; Omae K; Ohde Y Lung Cancer; 2018 Jan; 115():28-33. PubMed ID: 29290258 [TBL] [Abstract][Full Text] [Related]
17. Modality of failure following resection of stage I and stage II non-small cell lung cancer. Ramacciato G; Paolini A; Volpino P; Aurello P; Balesh AM; D'Andrea N; Del Grande E; Passaro U; Tosato F; Fegiz G Int Surg; 1995; 80(2):156-61. PubMed ID: 8530234 [TBL] [Abstract][Full Text] [Related]
18. Type of lymph node involvement and survival in pathologic N1 stage III non-small cell lung carcinoma. van Velzen E; de la Rivière AB; Elbers HJ; Lammers JW; van den Bosch JM Ann Thorac Surg; 1999 Apr; 67(4):903-7. PubMed ID: 10320225 [TBL] [Abstract][Full Text] [Related]
19. N1 non-small-cell lung cancer. A 20-year surgical experience. Casali C; Stefani A; Morandi U Asian Cardiovasc Thorac Ann; 2011 Jun; 19(3-4):217-24. PubMed ID: 21885545 [TBL] [Abstract][Full Text] [Related]
20. Extent of removal for mediastinal nodal stations for patients with clinical stage I non-small cell lung cancer: effect on outcome. Jeon HW; Moon MH; Kim KS; Kim YD; Wang YP; Park HJ; Park JK Thorac Cardiovasc Surg; 2014 Oct; 62(7):599-604. PubMed ID: 24420680 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]